Ear Worms can be a dreadful affliction – some song that plays over and over in your head that your don’t even know is there until it begins to drive you nuts. I am one of the afflicted and I have to figure out how they got there to be free of them. Recently, the […]
I’ve only included the response of Cosgrove and Krimsky from the Medscape article. The documentation for other parts of it are located below: The Cosgrove and Krimsky article [A Comparison of DSM-IV and DSM-5 Panel Members’ Financial Associations with Industry: A Pernicious Problem Persists] My comments on the article [must be crazy…] My comments on […]
So, let’s say that [hypothetically] that you thought the DSM-5 effort was misguided and wanted no part of it [hypothetically]. What could you do? Well, first, you could read this article that quotes Dr. Michael First, particularly the pieces highlighted in red: DSM-5 In the Homestretch—1. Integrating the Coding Systems Psychiatric Times By James Phillips, […]
notice who Dr. Cacciatore’s letter is addressed to: A Turning Point for DSM 5 Will the APA Trustees finally step to the plate? DSM5 in Distress by Allen J. Frances, M.D. March 21, 2012 Up until now, the leadership of the American Psychiatric Association has stubbornly defended the indefensible DSM 5 proposal that would turn […]
1980 was certainly a big year in America: Ronald Reagan was elected President; the DSM-III was published; the IBM PC was inching towards being released; the Bayh-Dole Act was signed… Huh? What’s the Bayh-Dole Act? Well, according to commenter, former Pharma Guy, Dan Abshear, it’s something we ought to know about – but I don’t. […]
Hat Tip to Jack Friday at Pharmagossip What’s an economic bubble? An economic bubble (sometimes referred to as a speculative bubble, a market bubble, a price bubble, a financial bubble, or a speculative mania) is “trade in high volumes at prices that are considerably at variance from intrinsic values”. While some economists deny that bubbles […]
Hat Tip to Ed Silverman for always being on top of this kind of article Publication Bias in Antipsychotic Trials: An Analysis of Efficacy Comparing the Published Literature to the US Food and Drug Administration Database by Erick H. Turner, Daniel Knoepflmacher, and Lee Shapley PLoS Medicine. 2012 9[3]:e1001189. [full text on-line] Background: Publication bias […]
When I was reviewing Dr. McGorry’s studies of early interventions in pre-psychotic people I summarized all of the studies done on their Ultra High Risk group [abstracts here]. This study from Germany is different in that they selected their subjects using more subtle criteria [EIPS – early initial prodromal state, having a 19% conversion rate […]
In 1980 with the coming of the DSM-III, Psychiatry lost its mind. Up until that point, psychoanalysis had been a part of psychiatry and a major contributor to the specialty, at least here in the US. It hadn’t been planned that way. The early European Analysts were mostly physicians, but there were notable exceptions – […]